Microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 - Roots Analysis

Mar 30, 2021

10 likes | 13 Views

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs For additional details, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1.tDrug Repurposing Service Providers Market, 2020 u2013 2030 2.tAntibody Discovery Services and Platforms Market (3rd Edition), 2020-2030 3.tLive Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020 - 2030 Contact: Gaurav Chaudhary 1 (415) 800 3415 44 (122) 391 1091 Gaurav.Chaudhary@rootsanalysis.com

kevin987

Download Presentation

Microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030 - Roots Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D